Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 2, 2003, Pages 342-347

  Bradley, Jeffrey D ^a,b   Wahab, Sasha ^a   Lockett, Mary Ann ^a   Perez, Carlos A ^a   Purdy, James A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elective nodal irradiation; Medically inoperable; Stage I lung cancer; Three dimensional conformal radiation therapy

Indexed keywords

IRRADIATION; PATIENT MONITORING; STATISTICAL METHODS; TUMORS;

ELECTIVE NODAL IRRADIATION;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0037625008     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04614-X     Document Type: Article

References (34)

1. Martini N., Beattie J.J. Jr. Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg. 74:1977;499-505.
2. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 96:1988;440-447.
3. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 non-small cell lung cancer. Ann Thorac Surg. 60:1995;615-622.
4. Haffty B.G., Goldberg N.B., Gerstley J. Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 15:1988;69-73.
5. Zhang H.X., Yin W.B., Zhang L.J., et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol. 14:1989;89-94.
6. Dosoretz D.E., Galmarini D., Rubenstein J.H., et al. Local control in medically inoperable lung cancer An analysis of its importance in outcome and factors determining the probability of tumor eradication . Int J Radiat Oncol Biol Phys. 27:1993;507-516.
7. Krol A.D.G., Aussems P., Noorduk V., et al. Local irradiation alone for peripheral stage I lung cancer Could we omit the elective regional nodal irradiation . Int J Radiat Oncol Biol Phys. 34:1996;297-302.
8. Slotman B.J., Antonisse I.E., Njo K.H. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol. 41:1996;41-44.
9. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer The Duke experience . Int J Radiat Oncol Biol Phys. 40:1998;149-154.
10. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer. 26:1999;137-142.
11. Kaplan M., Feinstein A. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis. 53:1974;457-481.
12. Piccirillo J., Creech C. Inclusion of comorbidity into oncology data registries. J Reg Mgmt. 26:1999;66-70.
13. Dixon W. BMDP statistical software. 1988;University of California Press, Los Angeles.
14. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
15. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
16. Cox D. Regression models and life tables. J Stat Soc. 34:(Series B):1972;187-220.
17. Rosenzweig KE, Sim SE, Mychalczak B, et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:681-685.
18. Arita T., Kuramitsu T. Bronchogenic carcinoma Incidence of metastases to normal sized lymph nodes . Thorax. 50:1995;1267-1269.
19. DeLeyn P.R., Vansteenkiste J.F. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg. 12:1997;706-712.
20. Tahara R.W., Lackner R.P. Is there a role for mediastinoscopy in patients with peripheral T1 lung cancers? Am J Surg. 180:2000;488-491.
21. Noordijk E.M., Poest Clement E.V.D., Wever A.M.J., et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol. 13:1988;83-89.
22. Kaskowitz L., Graham M.V., Emami B., et al. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 27:1993;517-523.
23. Graham P.H., Gebski V.J., Langlands A.O. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys. 31:1995;261-266.
24. Werner-Wasik M., Xiao Y., Pequignot E., et al. Assessment of lung cancer response after nonoperative therapy tumor diameter, bidimensional product, and volume: A serial CT scan-based study . Int J Radiat Oncol Biol Phys. 51:2001;56-61.
25. Rosenzweig K.E., Hanley J., Mah D., et al. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 48:2000;81-87.
26. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 44:1999;911-919.
27. Mah D., Hanley J., Rosenzweig K.E., et al. Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. Int J Radiat Oncol Biol Phys. 48:2000;1175-1185.
28. Barnes E.A., Murray B.R., Robinson D.M., et al. Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration. Int J Radiat Oncol Biol Phys. 15:2001;1091-1098.
29. Stevens C.W., Munden R.F., Forster K.M., et al. Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys. 51:2001;52-68.
30. Low D.A., Bradley J.D., Dempsey J.F., et al. A method for the four-dimensional measurement of normal and cancerous lung during free breathing. Int J Radiat Oncol Biol Phys. 54:2002;199. [Abstract].
31. Graham M.V., Jain N.L., Kahn M.G., et al. Validation and clinical usefulness of an objective plan evaluation model in the three-dimensional treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 27:(Suppl. 1):1993;240. [Abstract].
32. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Medically inoperable lung carcinoma The role of radiation therapy . Semin Radiat Oncol. 6:1996;98-104.
33. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy Update of a phase I trial . J Clin Oncol. 19:2001;127-136.
34. Graham M.V., Winter K., Purdy J.A., et al. Preliminary results of a Radiation Therapy Oncology Group trial (RTOG 9311), a phase I/II dose escalation study using three dimensional conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 51:2001;19-20.